Experienced in Peripheral Neuropathy

Isaac Kisinovsky

Quilmes, B, AR 
Experienced in Peripheral Neuropathy
Quilmes, B, AR 
OverviewLocationsClinical Research

Overview

Isaac Kisinovsky practices in Quilmes, Argentina. Mr. Kisinovsky is rated as an Experienced expert by MediFind in the treatment of Peripheral Neuropathy. His top areas of expertise are Gaucher Disease, Fabry Disease, Gaucher Disease Type 1, and Farber Lipogranulomatosis.

His clinical research consists of co-authoring 13 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Quilmes, B, Argentina
Other Locations
Your Health Sa, B, Argentina

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Randomized, Double-Blind, Parallel Group, Two-Dose Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease
A Multicenter, Randomized, Double-Blind, Parallel Group, Two-Dose Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease
Enrollment Status: Completed
Publish Date: June 29, 2021
Intervention Type: Biological
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Parallel-Group Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy Compared With Imiglucerase in Patients With Type I Gaucher Disease
A Multicenter, Randomized, Double-Blind, Parallel-Group Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy Compared With Imiglucerase in Patients With Type I Gaucher Disease
Enrollment Status: Completed
Publish Date: June 08, 2021
Intervention Type: Biological
Study Phase: Phase 3
View 1 Less Clinical Trial

13 Total Publications

Agalsidase alfa long-term effect on left ventricular hypertrophy in Fabry disease.
Agalsidase alfa long-term effect on left ventricular hypertrophy in Fabry disease.
Journal: Medicina
Published: June 22, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kisinovsky's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile